Deal Announcements

Meritage Pharma Closes First Venture Capital Round

Tuesday, June 17, 2008 6:03:00 AM PDT | VentureDeal Staff

San Diego, California -- Pharmaceutical company Meritage Pharma has announced that it has received $22.5 million in series A venture capital financing.

Meritage is developing pharmaceutical drugs intended for the treatment of allergic inflammation of the gastrointestinal tract.

Investors in the round included Domain Associates, Latterell Venture Partners and The Vertical Group.  The company said it would use the funding proceeds to continue development of its lead inflammation treatment candidate and to look for additional product opportunities.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1